Literature DB >> 9453421

Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence.

A Bahn1, P Gerner, U Martiné, F Bortolotti, S Wirth.   

Abstract

BACKGROUND/AIMS: Seroconversion to anti-HBs or the loss of HBsAg is usually associated with complete elimination of the replicative hepatitis B virus. Usually in these patients hepatitis B virus DNA (HBV DNA) becomes undetectable. Routine controls of patients who underwent anti-HBs seroconversion by more sensitive tests showed that in some cases the virus persisted in the patient. Therefore the aim of our study was to evaluate if virus persistence could also be found in children with chronic hepatitis B after anti-HBs seroconversion. The virus pool should be characterized before and after seroconversion.
METHODS: Viral DNA was extracted from nine HBsAg negative or anti-HBs positive sera of children, previously diagnosed as chronic HBsAg carriers. HBV DNA was amplified by polymerase chain reaction. Subsequently the nucleotide sequences of the polymerase chain reaction product in the a-determinant region (aa 121-161) were analyzed on an automatic fluorescent sequencer.
RESULTS: In the sera of seven children, HBV DNA was detected in the HBsAg negative phase of the HBV infection. Mutations in codons 122, 125, 127, 131, 134, 143, 159 and 161 of the S gene could be documented, resulting in amino acid changes. In three patients the sequence analysis revealed changes in the HBV genotype from genotype A (serotype adw) to genotype D (serotype ayw) during seroconversion to anti-HBs.
CONCLUSIONS: These data demonstrate that persistence of the hepatitis B virus can also occur in HBsAg negative and anti-HBs positive children. After loss of HBsAg, no specific HBV variant was identified. Although a conclusive explanation for the selection process cannot be provided, it remains a fact that the 'surviving' viral strain was mostly represented by genotype D.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9453421     DOI: 10.1016/s0168-8278(97)80139-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

Review 1.  Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies.

Authors:  Ralph Carmel; Mona Sarrai
Journal:  Curr Hematol Rep       Date:  2006-03

2.  Genetic linkage of hepatitis B virus in peripheral blood leukocytes provides evidence for contamination.

Authors:  Chloe L Thio; Stuart C Ray; Sibnarayan Datta; Rajesh Panigrahi; Avik Biswas; Runu Chakravarty
Journal:  J Virol       Date:  2010-02       Impact factor: 5.103

Review 3.  The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

4.  Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants.

Authors:  Olivier Lada; Yves Benhamou; Thierry Poynard; Vincent Thibault
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  Occult hepatitis B infection in the immigrant population of Sicily, Italy.

Authors:  Fabio Tramuto; Carmelo M Maida; Giuseppina M E Colomba; Paola Di Carlo; Giovanni Mazzola; Valentina Li Vecchi; Mario Affronti; Giuseppe Montalto; Francesco Vitale
Journal:  J Immigr Minor Health       Date:  2013-08

6.  Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology.

Authors:  C Berasain; M Betés; A Panizo; J Ruiz; J I Herrero; M P Civeira; J Prieto
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

7.  Identification and characterization of genotype A and D recombinant hepatitis B virus from Indian chronic HBV isolates.

Authors:  Ranjit Chauhan; Syed-Naqui Kazim; Manoj Kumar; Jayashree Bhattacharjee; Narayanasamy Krishnamoorthy; Shiv-Kumar Sarin
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

8.  Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virus.

Authors:  Suzan D Pas; Nathalie Tran; Robert A de Man; C Burghoorn-Maas; Guy Vernet; Hubert G M Niesters
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

9.  Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.

Authors:  Severine Margeridon-Thermet; Nancy S Shulman; Aijaz Ahmed; Rajin Shahriar; Tommy Liu; Chunlin Wang; Susan P Holmes; Farbod Babrzadeh; Baback Gharizadeh; Bozena Hanczaruk; Birgitte B Simen; Michael Egholm; Robert W Shafer
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

10.  Hepatitis B virus S gene escape mutants.

Authors:  Michael A Purdy
Journal:  Asian J Transfus Sci       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.